Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients (Q34037828)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients |
scientific article |
Statements
1 reference
Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients (English)
1 reference
Wyndham Wilson
1 reference
Betty Y Chang
1 reference
Michelle Francesco
1 reference
Martin F M De Rooij
1 reference
Padmaja Magadala
1 reference
Susanne M Steggerda
1 reference
Min Mei Huang
1 reference
Annemieke Kuil
1 reference
Sarah E M Herman
1 reference
Stella Chang
1 reference
Steven T Pals
1 reference
Adrian Wiestner
1 reference
Joseph J Buggy
1 reference
Laurence Elias
1 reference
12 August 2013
1 reference
1 reference
1 reference
Identifiers
1 reference